Replication-selective virotherapy for cancer: Biological principles, risk management and future directions

Kirn, David; Martuza, Robert L.; Zwiebel, James
July 2001
Nature Medicine;Jul2001, Vol. 7 Issue 7, p781
Academic Journal
In the search for novel cancer therapies that can be used in conjunction with existing treatments, one promising area of research is the use of viral vectors and whole viruses. This review describes the underlying biological principles and current status of the field, outlines approaches for improving clinical effectiveness and discusses the unique safety and regulatory issues surrounding viral therapies.


Related Articles

  • Viruses as oncolytic agents: A new age for `therapeutic' viruses? Kenney, Shannon; Pagano, Joseph S. // JNCI: Journal of the National Cancer Institute;8/17/94, Vol. 86 Issue 16, p1185 

    Editorial. Discusses the potential use of viruses in lysing human cancer cells. Historical background; Types of viruses proposed as potential oncolytic agents; Advantages and disadvantages of Newcastle disease virus (NDV) and herpes simplex virus (HSV) as oncolytic agents; Pitfalls.

  • Viruses and cancer. Nelson, Nancy J.; Nelson, N J // JNCI: Journal of the National Cancer Institute;10/20/99, Vol. 91 Issue 20, p1709 

    Focuses on the use of viruses to treat cancer. Historical background; Outcome of clinical trials; How the interest on viruses for cancer treatment faded.

  • Oncolytic Viruses: What's Next? Bell, John C. // Current Cancer Drug Targets;Mar2007, Vol. 7 Issue 2, p127 

    Cancer is a complex disease that often eludes successful treatment due to its propensity to evolve or adapt in the face of current therapeutic regimes. It is reasonable to suggest that sophisticated therapeutics that can attack cancers in multiple, but targeted ways, will be necessary in order...

  • Scientific interest in Newcastle disease virus is reviving. Nelson, Nancy J.; Nelson, N J // JNCI: Journal of the National Cancer Institute;10/20/99, Vol. 91 Issue 20, p1708 

    Reports on the focus of scientific interest in Newcastle disease virus (NDV) therapy for the treatment of cancer. Historical background on the isolation of NDV; Cellular mechanisms that have been proposed; Role of physician William A. Cassel in NDV therapy.

  • 838. 10 Year Follow-Up of 146 Advanced Stage NSCLC Patients Who Received Adenoviral Based Therapy. Nemunaitis, John; Pappen, Been; Arzaga, Rosemarie; Cunningham, Casey; Senzer, Neil // Molecular Therapy;Jun2006, Vol. 13, pS324 

    We report the first long-term follow-up of adenoviral vector based therapeutics patients who previously received anticancer therapy. Over the period of 10/26/95 to 8/15/05 146 patients with stage IIIB/ IV NSCLC were treated as out patients. Patients participated in 1 of 8 adenoviral based...

  • Oncolytic viral therapy for pancreatic cancer: current research and future directions. Ady, Justin W.; Heffner, Jacqueline; Klein, Elizabeth; Yuman Fong // Oncolytic Virotherapy;2014, Vol. 3, p35 

    The development of targeted agents and chemotherapies for pancreatic cancer has only modestly affected clinical outcome and not changed 5-year survival. Fortunately the genetic and molecular mechanisms underlying pancreatic cancer are being rapidly uncovered and are providing opportunities for...

  • Oncolytic virus therapy for cancer. Goldufsky, Joe; Sivendran, Shanthi; Harcharik, Sara; Pan, Michael; Bernardo, Sebastian; Stern, Richard H.; Friedlander, Philip; Ruby, Carl E.; Saenger, Yvonne; Kaufman, Howard L. // Oncolytic Virotherapy;2013, Vol. 2, p31 

    The use of oncolytic viruses to treat cancer is based on the selection of tropic tumor viruses or the generation of replication selective vectors that can either directly kill infected tumor cells or increase their susceptibility to cell death and apoptosis through additional exposure to...

  • E1A genes of adenovirus type 2 and type 5 are expressed at different levels. Möritz, C.; Dobbelstein, M. // Archives of Virology;Jun2006, Vol. 151 Issue 6, p1085 

    Adenoviruses are an extensively studied system for modeling oncogenesis and for experimental cancer therapy. The most commonly analyzed virus types are 2 and 5, and little distinction has been made between them in past studies. Adenoviruses used for therapeutic purposes are frequently hybrids...

  • Cancer Gene Therapy: The power of negative thinking. Lotze, M. T. // Gene Therapy;Feb2006, Vol. 13 Issue 3, p191 

    The article discusses the pathways for the gene therapy of cancer. The first pathway in gene therapy was discussed. The use of genetic constructs to confer novel properties of the cell, the second pathway, was described. The third pathway is to use nominally tumor-selective viruses that mediate...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics